NCT01785147View on ClinicalTrials.gov

Efficacy and Safety of BP1.4979 in Smoking Cessation

PHASE2CompletedINTERVENTIONAL
Enrollment

219

Participants

Timeline

Start Date

February 28, 2013

Primary Completion Date

July 31, 2014

Study Completion Date

October 31, 2014

Conditions
Tobacco Addiction
Interventions
DRUG

BP1.4979

BP1.4979 at 3mg, 10mg, 15mg or placebo during 3 months.

DRUG

Placebo

Trial Locations (1)

94800

Hôpital Paul Brousse, Villejuif

Sponsors

Lead Sponsor

Bioprojet
All Listed Sponsors
lead

Bioprojet

OTHER

NCT01785147 - Efficacy and Safety of BP1.4979 in Smoking Cessation | Biotech Hunter | Biotech Hunter